与结合性和功能性活性相关的抗体基因特征在疟疾疫苗衍生的人类mAbs中
Camila H Coelho1,2,3,4, Susanna Marquez5, Bergeline C Nguemwo Tentokam1
1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
辅助剂Alhydrogel®和AS01对疟疾疫苗抗体反应的影响不同. AS01配方诱导了更广泛的抗体多样性,而Alhydrogel®对Pfs230D1抗原的结合频率更高.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 寄生虫学的寄生虫学
背景情况:
- 辅助剂对于提高疫苗疗效至关重要.
- 了解辅助剂对抗体库的影响对于疟疾疫苗开发至关重要.
- Pfs230D1抗原是疟疾传播阻断疫苗的目标.
研究的目的:
- 调查Alhydrogel®和AS01辅助剂如何影响疟疾疫苗接种后的抗体谱.
- 为了比较不同辅助剂配方诱导的抗体克隆型多样性,结合和功能.
主要方法:
- 针对Pfs230D1的重组单克隆抗体 (mAbs) 由用Alhydrogel®或AS01.01配制的Pfs230D1接种的参与者产生.
- 鉴定了抗体克隆型多样性,抗原结合频率和功能活性.
- 评估了特定抗体基因,如IGHV1-69的作用,以确定它们的结合和阻断传播能力.
主要成果:
- 与AS01.01相比,Alhydrogel®配方导致抗Pfs230D1mAbs与抗原结合的频率更高.
- 功能性mAbs的频率在Alhydrogel®和AS01组之间是可比的.
- AS01配方产生的功能性抗体来源于比Alhydrogel®更广泛的生殖系序列.
- 所有IGHV1-69衍生的mAbs,无论辅助剂如何,都与Pfs230D1结合,但未能阻止寄生虫传播.
结论:
- 辅助剂的选择显著影响了对疟疾疫苗的抗体反应.
- AS01可以提供更广泛的抗体多样性,而Alhydrogel®可以增强抗原结合.
- 像IGHV1-69这样的特定抗体基因,尽管与抗原结合,但可能不会产生阻断传播的活性.
- 这些发现为基于Plasmodium抗原的疫苗设计提供了辅助剂选择的信息.
更多相关视频
09:57Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
相关概念视频
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Cross-reactivity
Humoral Immune Responses
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
